AMI Cardiogenic Shock

Early Stabilization Can Improve Outcomes in Cardiogenic Shock

Impella® heart pumps have the ability to stabilize patient hemodynamics, unload the left ventricle, perfuse end organs, and allow for recovery of the native heart in patients with ongoing cardiogenic shock. Identifying patients early, treating them with a proven protocol, and following them with hemodynamic monitoring and aggressive down titration of inotropes and vasopressors can reverse the downward spiral of cardiogenic shock and help patients achieve myocardial recovery.

Explore the Education Library


Optimizing AMICS Patient Care Prior to Leaving the Cath Lab

Amir Kaki, MD, describes best practices and practical considerations for optimizing care of patients with AMI cardiogenic shock prior to leaving the cath lab.


Achieving >70% AMI Cardiogenic Shock Survival: Insight from National Cardiogenic Shock Initiative (NCSI) Study

William O'Neill, MD, explains how cardiac power output (CPO) and pulmonary artery pulsatility index (PAPI) are used to drive care for patients after angioplasty.


Implementing a Cardiogenic Shock Protocol to Improve Outcomes

Alexander Truesdell, MD, and Benham Tehrani, MD, discuss implementing a cardiogenic shock protocol.